Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
NCT ID:
NCT02899793
Group ID:
EG000
Title:
Pembrolizumab
Description:
Pembrolizumab 200 mg, Q3W, IV Infusion, Day 1 of each 3 week cycle
Pembrolizumab: Pembrolizumab 200 mg (fixed dose) IV every 3 weeks (+/- 3 days) until progression or adverse effects prohibit therapy
Deaths Number Affected:
12
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
25
Other Number Affected:
25
Other Number At Risk:
25
Study:
NCT02899793
Results Section:
NCT02899793
Adverse Events Module:
NCT02899793